Shah Pritesh 4
4 · NovoCure Ltd · Filed Nov 8, 2023
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Shah Pritesh
Chief Commercial Officer
Transactions
- Sale
Ordinary Shares
2023-11-07$12.65/sh−382$4,832→ 124,511 total
Footnotes (1)
- [F1]Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.